Latest Neurofibrillary tangle Stories
CHICAGO, ILLINOIS--(Marketwire - July 30, 2008) - Allon Therapeutics Inc.
In years to come, scientists and pharmaceutical companies may look at the 2008 International Conference on Alzheimer's disease (ICAD) as a water-shed in the development of truly effective disease modifying treatments.
Researchers at Scotland's University of Aberdeen say a new drug they've developed holds great promise in slowing the progression of Alzheimer's disease.
CHICAGO, ILLINOIS--(Marketwire - July 28, 2008) - Allon Therapeutics Inc.
A Dutch woman who reached 115 years of age and remained mentally sharp throughout life also had a healthy brain when she died, a new study finds. The woman's brain showed almost no evidence of Alzheimer's disease.
By Michelle Rizzo NEW YORK (Reuters Health) - Brain lesions known as neurofibrillary tangles, such as those seen in Alzheimer's disease, are also associated with impaired gait in older subjects with or without dementia, according to a postmortem study.
Researchers from the Rush Alzheimer's Disease Center found that plaques and tangles in the brain, the changes seen in people with Alzheimer's disease (AD), are more likely to be expressed as dementia in women than in men.
A team of scientists has discovered three molecules â€“â€“ from a search of 58,000 compounds â€“â€“ that appear to inhibit a key perpetrator of Alzheimer's disease.
Researchers at the University of Minnesota were able to reverse memory loss in mice with significant brain degeneration for the first time, a breakthrough that offers hope to the estimated 4 million people living with Alzheimer's disease.
By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - Tests on mice suggest the brain damage caused by Alzheimer's disease may be at least partly reversible, researchers reported Thursday.